Immune responses to a class II helper peptide epitope in patients with stage III/IV resected melanoma.

Wong, Raymond

Immune responses to a class II helper peptide epitope in patients with stage III/IV resected melanoma. [electronic resource] - Clinical cancer research : an official journal of the American Association for Cancer Research Aug 2004 - 5004-13 p. digital

Publication Type: Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't

1078-0432

10.1158/1078-0432.CCR-04-0241 doi


Age Factors
Alleles
Antigens, Neoplasm
CD3 Complex--biosynthesis
CD4 Antigens--biosynthesis
CD4-Positive T-Lymphocytes--immunology
CD8-Positive T-Lymphocytes--immunology
Cancer Vaccines--chemistry
Cell Line, Tumor
Cell Proliferation
Dendritic Cells--cytology
Enzyme-Linked Immunosorbent Assay
Epitopes--chemistry
Female
Flow Cytometry
Granzymes
HLA Antigens--chemistry
HLA-DR Antigens--genetics
Humans
Immunotherapy--methods
Leukocytes, Mononuclear--immunology
Lipid A--analogs & derivatives
Lymphocytes--metabolism
MART-1 Antigen
Male
Melanoma--metabolism
Microscopy, Fluorescence
Neoplasm Proteins--chemistry
Peptides--chemistry
Pilot Projects
Saponins--pharmacology
Serine Endopeptidases--chemistry
T-Lymphocytes--metabolism
Th1 Cells--immunology
Th2 Cells--immunology
Time Factors
Treatment Outcome